Press Releases

  • VolitionRx Limited Announces First Quarter 2019 Financial Results and Business Update

  • VolitionRx Limited Executes a Contract for Clinical Trial Program in Lung Cancer

  • VolitionRx Limited Schedules First Quarter 2019 Earnings Conference Call and Business Update

  • VolitionRx Limited Hosts Capital Markets Day at the New York Stock Exchange and Issues Company Update Report

  • VolitionRx Limited Signs Memorandum of Understanding with Texas A&M University for Potential Collaboration to Develop Nu.QTM Veterinary Diagnostics

  • VolitionRx Limited Extends Clinical Trial Program in Lung Cancer

  • VolitionRx Limited Signs Memorandum of Understanding with Fosun Long March in China

  • VolitionRx Limited to Present at Conferences in March & April 2019

  • VolitionRx Limited to Present at Conferences in the U.S. Next Week

  • VolitionRx Limited Announces Full Fiscal Year 2018 Financial Results and Business Update

arrow-downarrow-leftarrow-rightarrowchevron-downcircle-link--redcircle-linkcloseplayplus